ACADIA PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 9, 2010

Attached files

file filename
10-K - FORM 10-K - ACADIA PHARMACEUTICALS INCd10k.htm
EX-21.1 - LIST OF SUBSIDIARIES OF THE REGISTRANT - ACADIA PHARMACEUTICALS INCdex211.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT TO 18 USC SECTION 1350 - ACADIA PHARMACEUTICALS INCdex322.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) - ACADIA PHARMACEUTICALS INCdex311.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) - ACADIA PHARMACEUTICALS INCdex312.htm
EX-10.6 - VOLUME SUBMITTER DEFINED CONTRIBUTION PLAN - ACADIA PHARMACEUTICALS INCdex106.htm
EX-32.1 - CERTIFICATION OF CEO PURSUANT TO 18 USC SECTION 1350 - ACADIA PHARMACEUTICALS INCdex321.htm
EX-10.7 - ADOPTION AGREEMENT FOR 401(K) PLAN - ACADIA PHARMACEUTICALS INCdex107.htm
EX-10.21 - AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT - ACADIA PHARMACEUTICALS INCdex1021.htm
EX-10.25 - LEASE AMENDMENT DATED 01/22/2010 - ACADIA PHARMACEUTICALS INCdex1025.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-153347 and 333-161059) and the Registration Statements on Form S-8 (Nos. 333-115956, 333-128290, 333-137557, 333-146398, 333-153346 and 333-161057) of ACADIA Pharmaceuticals Inc. of our report dated March 9, 2010 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP

San Diego, California

March 9, 2010

ACADIA PHARMACEUTICALS INC Reports

Also read